Skip to main content
Assets
Ping An Insurance logo
2318.HKEX
Ping An Insurance
Financials · Life & Health Insurance

Ping An Insurance (Group) Company of China, Ltd. provides financial products and services in the People's Republic of China.

HQ: ChinaListed: Hong Kong

Historical AI Consensus

Audit every published iPulse AI forecast batch and immutable historical research document for Ping An Insurance.

Historical AI Consensus

This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.

Symbol
2318.HKEX
Batch
7
Published
September 20, 2026
AI Advisors
14

Historical AI Consensus Investment Thesis

Ping An Insurance (2318) Stock Forecast and AI Rating

Deep analysis published Original pricing snapshot 12 min read
Published 1-Year and 5-Year Forecast Outlook

Forecast targets and rating

Published batch rating

STRONG BUY

Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.

2027

1-Year

STRONG BUY

HK$61

+14.7%+21.4% incl. dividends
2031

5-Year

STRONG BUY

HK$93

+75.1%+132.1% incl. dividends

Published batch insight

Surging Underwriting Margins and Liability Repricing Overcome China Macro Friction

There is high consensus that aggressive agency restructuring and regulatory policy repricing have re-established core underwriting compounding. The primary driver is double-digit new business value expansion alongside contractual service margin release, while persistent sovereign bond yield compression remains the principal friction.

Deep Forecast Analysis by iPulse AI Engine

This analysis preserves the original published batch. Audit published forecasts in full transparency

Michael Burry (Vulture) advisor portraitUniversal Investor (Polymath) advisor portraitRay Dalio (Strategist) advisor portraitSherlock Holmes (Whistleblower) advisor portraitJ.P. Morgan (Titan) advisor portraitElon Musk (Visionary) advisor portraitSuperintelligence (Anthropologist) advisor portraitMachiavelli (Insider) advisor portraitWarren Buffett (Value Purist) advisor portrait

Michael Burry (Vulture), Universal Investor (Polymath), Ray Dalio (Strategist), Sherlock Holmes (Whistleblower), J.P. Morgan (Titan), Elon Musk (Visionary), Superintelligence (Anthropologist), Machiavelli (Insider), Warren Buffett (Value Purist). Some archetypes run in multiple modes, resulting in 14 advisors total.

Computed on these frontier AI models
Gemini AI model logoGeminiClaude AI model logoClaudeChatGPT AI model logoChatGPT

Full published thesis

Executive Summary

If you invested $10,000 in Ping An Insurance at the forecast anchor (2026-09-18): $23,363 in five years versus $13,892 for S&P 500 benchmark.

Five-year synthesized consensus forecast for Ping An InsuranceThe diagram shows the synthesized consensus value path for Ping An Insurance, forecast milestones, and a comparison with S&P 500 benchmark. including estimated net dividends of 5.8% per year.$10,000$15,000$20,000$25,000$23,363 (+134%)$13,892 (+38.9%)Anchor2026-09-182027(1Y)2028(2Y)2029(3Y)2030(4Y)2031(5Y)
Ping An Insurance · Synthesized ConsensusS&P 500 benchmark

* Return is calculated incl. 5.8% net dividend yield for Ping An Insurance.

Figure: Five-year synthesized consensus value path for Ping An Insurance compared with S&P 500 benchmark. The path uses the synthesizer’s normalized opinion weights.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each step

Frozen forecast from 18 Sept 2026. Prices in HKD; returns exclude dividends. Each quarter is compounded from the previous quarter.

Anchor: 53.2 HKD1-year price return: +14.73%5-year price return: +75.07%

Swipe the table horizontally to read every column.

Twenty quarterly synthesized price forecasts in HKD, with returns and rationale
QuarterTarget (HKD)Quarter returnTotal returnForecast rationale
Q4 202654.93+3.25%+3.25%Third-quarter operating profit resilience and steady contractual service margin accretion support steady equity appreciation, counterbalancing emerging-market foreign exchange fluctuations and global interest rate headwinds.
Q1 202757.07+3.90%+7.27%Full-year reporting confirms expanding new business value and modest dividend growth, prompting value allocators to accumulate shares as real estate impairment charges visibly recede.
Q2 202758.90+3.22%+10.72%Implementation of lowered guaranteed policy crediting rates expands life underwriting margins, offsetting minor post-dividend seasonal adjustments and subdued commercial banking loan demand.
Q3 202761.04+3.62%+14.73%Interim disclosures validate accelerating healthcare ecosystem monetization and resilient property and casualty underwriting, sustaining modest valuation repair toward tangible book value.
Q4 202763.08+3.34%+18.56%Mainland domestic liquidity channeled through Southbound Connect absorbs external geopolitical risk discounts, providing durable price support around an attractive forward dividend yield.
Q1 202865.81+4.33%+23.70%Annual financial statements reveal operating profit compounding near high-single digits, encouraging institutional re-weighting as balance-sheet credit provisions continue their downward trajectory.
Q2 202867.01+1.82%+25.96%Ex-dividend price adjustments and lingering sovereign bond reinvestment drag temper upward velocity, but high policy persistency preserves foundational balance-sheet capital accumulation.
Q3 202868.77+2.63%+29.27%Expanding career agent productivity and automated claims settlement compress group operational expense ratios, driving steady earnings growth through the late-summer reporting cycle.
Q4 202870.91+3.12%+33.30%Accelerating private retirement annuity inflows and defensive portfolio positioning bolster investor demand, enabling the equity to advance steadily amid broader regional macroeconomic consolidation.
Q1 202973.59+3.77%+38.33%Audited results confirm another progressive dividend increase, while prospective convertible bond maturity considerations focus institutional attention on underlying diluted per-share earnings power.
Q2 202974.93+1.82%+40.85%Convertible bond conversion dynamics and seasonal dividend deductions generate mild trading friction, though healthy recurring life underwriting cash flows prevent meaningful valuation pullbacks.
Q3 202977.00+2.75%+44.73%Resolution of capital structure adjustments clarifies normalized earnings per share, refocusing market attention on growing contractual service margin balances and stable banking credit metrics.
Q4 202979.01+2.62%+48.52%Deepening integration of eldercare living communities boosts customer retention and cross-sell ratios, supporting measured share price appreciation heading into the fiscal year-end.
Q1 203081.66+3.35%+53.50%Full-year reporting confirms return on equity solidifying above thirteen percent, allowing the price-to-book valuation multiple to grind closer to historical mid-cycle averages.
Q2 203082.82+1.42%+55.68%Seasonal dividend payouts temporarily moderate momentum, but disciplined asset-liability duration matching shields portfolio income from incremental domestic policy rate adjustments.
Q3 203085.06+2.70%+59.88%Interim results demonstrate mature operating stability across retail life, health, and property lines, driving quiet institutional accumulation in Hong Kong trading.
Q4 203087.01+2.29%+63.55%Enterprise-wide artificial intelligence deployment further optimizes operational efficiency, offsetting modest banking spread compression and supporting a constructive year-end finish.
Q1 203189.70+3.10%+68.61%Audited disclosures show record contractual service margin reserves and exceptional capital adequacy, prompting selective upgrades from global emerging-market income allocators.
Q2 203191.36+1.84%+71.72%Ex-dividend price adjustment is readily absorbed as market participants anticipate consistent second-half cash flows backed by robust comprehensive solvency margins.
Q3 203193.14+1.95%+75.07%The five-year scenario concludes with the equity trading at a normalized valuation multiple, reflecting resilient cash compounding and defensive healthcare ecosystem synergies.

Ping An presents a compelling operational rehabilitation where improving underwriting quality and liability repricing decouple intrinsic earning power from domestic macroeconomic headwinds. The core economic thesis rests on the successful transition of the life distribution model toward an elite, high-productivity salesforce, complemented by regulatory interventions that have lowered guaranteed crediting rates from 3.5% toward 2.5%. This shift expands new business value margins and amortizes an unassailable contractual service margin exceeding CNY 720 billion. Trading at approximately 0.81 times attributable book value, the equity provides a substantial margin of safety, while dividend yields near 5.5% establish a firm total-return floor. The foremost counterargument centers on persistent domestic low interest rates, which dilute fixed-income reinvestment yields and threaten negative spread drag on legacy non-participating portfolios.

Key insights

  • Regulatory liability restructuring toward participating policies transfers asset-yield volatility to policyholders, insulating core operating profit after tax from low sovereign yields.
  • Captive healthcare and eldercare ecosystem integration drives 35% lower acquisition costs and superior policy persistency across 250 million retail customers.
  • Attributable equity surpassing one trillion renminbi provides robust statutory solvency, though potential convertible bond dilution demands disciplined per-share valuation modeling.

Deep Dive

Prevailing market sentiment treats Ping An as a distressed cyclical conglomerate ensnared by China's property slump, low benchmark yields, and sluggish consumer confidence. The crowd assumes low bond yields will permanently trigger negative spread losses, pricing the stock at a depressed 0.81 times book value and 5.4 times earnings under the belief that balance-sheet credit impairments are permanent features.